These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2428019)

  • 1. Selective osteoblast mitogens can be extracted from prostatic tissue.
    Koutsilieris M; Rabbani SA; Goltzman D
    Prostate; 1986; 9(2):109-15. PubMed ID: 2428019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of human prostatic mitogens on rat bone cells and fibroblasts.
    Koutsilieris M; Rabbani SA; Goltzman D
    J Endocrinol; 1987 Dec; 115(3):447-54. PubMed ID: 2450942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.
    Koutsilieris M; Rabbani SA; Bennett HP; Goltzman D
    J Clin Invest; 1987 Oct; 80(4):941-6. PubMed ID: 2443538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-binding growth factor isolated from human prostatic extracts.
    Mydlo JH; Bulbul MA; Richon VM; Heston WD; Fair WR
    Prostate; 1988; 12(4):343-55. PubMed ID: 3393496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic factors in prostatic tissue and expressed prostatic secretion.
    Tackett RE; Heston WD; Parrish RF; Pletscher LS; Fair WR
    J Urol; 1985 Jan; 133(1):45-8. PubMed ID: 2578068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential mitogenic activity for myoblast-like cells can be extracted from uterine leiomyoma tissues.
    Koutsilieris M; Michaud J; Nikolis A
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1665-70. PubMed ID: 2240121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A growth factor in extracts of human prostatic tissue.
    Lawson RK; Story MT; Jacobs SC
    Prog Clin Biol Res; 1981; 75A():325-36. PubMed ID: 6175979
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the pathogenesis of osteoblastic metastases by prostate cancer.
    Goltzman D; Bolivar I; Rabbani SA
    Adv Exp Med Biol; 1992; 324():165-71. PubMed ID: 1283497
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitogenic factor in human prostate extracts.
    Jacobs SC; Lawson RK
    Urology; 1980 Nov; 16(5):488-91. PubMed ID: 6969486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors.
    Dahlberg E; Snochowski M; Gustafsson JA
    Prostate; 1980; 1(1):61-70. PubMed ID: 6169071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate growth factor in the extracts of benign prostatic hypertrophy. Partial purification and physicochemical characterization.
    Jinno H; Ueda K; Otaguro K; Kato T; Ito J; Tanaka R
    Eur Urol; 1986; 12(1):41-8. PubMed ID: 2419135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin in human prostate tissue.
    van Sande M; Van Camp K
    Urol Res; 1981; 9(5):241-4. PubMed ID: 6171084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and partial characterization of prostate-derived growth factor.
    Maehama S; Li D; Nanri H; Leykam JF; Deuel TF
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8162-6. PubMed ID: 2430278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma.
    Mydlo JH; Michaeli J; Heston WD; Fair WR
    Prostate; 1988; 13(3):241-7. PubMed ID: 2463616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
    Shain SA; Koger JD
    Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors in the prostate.
    Matuo Y; Nishi N; Wada F
    Arch Androl; 1987; 19(3):193-210. PubMed ID: 2461175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.